Review
The therapeutics of migraine
Affiliations
- PMID: 8386957
Item in Clipboard
Review
The therapeutics of migraine
Curr Opin Neurol Neurosurg.
1993 Apr.
Abstract
This paper reviews the therapeutics of migraine in the context of the clinical problem and its prevalence. General principles of pharmacotherapy for symptomatic and preventive medications are provided. Two new drugs, sumatriptan (recommended for acute symptomatic therapy), and valproic acid (recommended for migraine prevention), are reviewed. The clinical effectiveness and the mechanisms of action of these drugs are discussed.
Similar articles
-
Sumatriptan: a new serotonin agonist for the treatment of migraine headache.Am Fam Physician. 1993 Feb 15;47(3):645-7. Am Fam Physician. 1993. PMID: 8382004 Review.
-
Sumatriptan in the treatment of migraine.Neurology. 1993 Jun;43(6 Suppl 3):S43-7. Neurology. 1993. PMID: 8389011 Review.
-
[Sumatriptan in clinical practice].Ned Tijdschr Geneeskd. 1993 Apr 24;137(17):850-5. Ned Tijdschr Geneeskd. 1993. PMID: 8387649 Review. Dutch. No abstract available.
-
Sumatriptan: a new approach to migraine.Drug Ther Bull. 1992 Oct 26;30(22):85-7. Drug Ther Bull. 1992. PMID: 1330474 Review. No abstract available.
-
[Sumatriptan (Imigran) to patients with hemiplegic migraine?].Ugeskr Laeger. 1992 Aug 10;154(33):2271. Ugeskr Laeger. 1992. PMID: 1329297 Danish. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical